Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)			1 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	May 21, 2021 USD ($)	Apr. 27, 2020 USD ($)	May 31, 2022 shares	Mar. 31, 2022 shares	Dec. 31, 2021 shares	Apr. 30, 2019 shares	Jun. 30, 2022 shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance								$ 36,980	$ 36,980	$ 3,633
Accounts Receivable, after Allowance for Credit Loss, Current, Total								273,451	273,451
Gain (Loss) on Extinguishment of Debt, Total									0	1,466,113
Revenue, Remaining Performance Obligation, Amount								0	0
Contract with Customer, Asset, after Allowance for Credit Loss, Total								0	0
Contract with Customer, Liability, Total										0
Marketing and Advertising Expense, Total									14,332,235	15,835,139
Federal Deposit Insurance Corporation Premium Expense										250,000
Cash, Uninsured Amount								5,752,550	5,752,550	23,508,953
Net Income (Loss) Including Impairment									(74,086,731)
Goodwill and Intangible Asset Impairment, Total									60,955,970	$ 0
Net Income (Loss), Excluding Impairment									(13,130,761)
Working Capital								$ 10,725,991	10,725,991
Restructuring Costs, Total									$ 602,092
Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member]
Number of Major Customers										0
Paycheck Protection Program CARES Act [Member]
Proceeds from Issuance of Debt		$ 1,456,100
Gain (Loss) on Extinguishment of Debt, Total	$ 1,466,113
Manufacturing Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)									5 years
Software [Member]
Property, Plant and Equipment, Useful Life (Year)									3 years
Minimum [Member]
MerchantProcessingFee								2.50%	2.50%
Maximum [Member]
MerchantProcessingFee								5.00%	5.00%
Cure Based Development, Llc [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares						15,250,000
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)						5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares) | shares			458,877	444,243	466,713	15,250,000	409,505	3,928,792
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares						8,750,000			2,187,500
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)						5 years